Skip to main content
. 2018 Oct 10;17(1):594–602. doi: 10.3892/ol.2018.9564

Figure 2.

Figure 2.

Survival outcomes of patients treated with and without docetaxel. Kaplan-Meier curves displaying (A) overall survival rates and (B) progression-free survival rates for patients in the docetaxel, nedaplatin and radiotherapy group (blue) and the S-1, nedaplatin and radiotherapy, plus nedaplatin and radiotherapy group (green). Rhombus, censored value.